Entry Detail



General Information

Database ID:exR0373069
RNA Name:HCG18
RNA Type:lncRNA
Chromosome:chr6
Starnd:-
Coordinate:
Start Site(bp):30286690End Site(bp):30327382
External Links:ENSG00000231074



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AKT1S1
chr19
49869033
49878459
-
AKT2
chr19
40230317
40285536
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-15b-5p
chr3
160404607
160404628
+
hsa-miR-545-5p
chrX
74287164
74287185
-
hsa-miR-324-5p
chr17
7223343
7223364
-
hsa-miR-4677-3p
chr1
243346225
243346246
+
hsa-miR-424-5p
chrX
134546680
134546701
-
hsa-miR-148b-3p
chr12
54337278
54337299
+
hsa-miR-4739
chr17
79707216
79707240
-
hsa-miR-3174
chr15
90006764
90006786
+
hsa-miR-195-5p
chr17
7017667
7017687
-
hsa-miR-148a-3p
chr7
25949922
25949943
-
hsa-miR-449c-5p
chr5
55172313
55172337
-
hsa-miR-449a
chr5
55170586
55170607
-
hsa-miR-449b-5p
chr5
55170706
55170727
-
hsa-miR-16-5p
chr3
160404754
160404775
+
hsa-miR-34a-5p
chr1
9151735
9151756
-
hsa-miR-4756-5p
chr20
54068452
54068474
-
hsa-miR-1321
chrX
85835832
85835849
+
hsa-miR-499a-5p
chr20
34990408
34990428
+
hsa-miR-3614-5p
chr17
56891319
56891341
-
hsa-miR-495-3p
chr14
101033804
101033825
+
hsa-miR-3605-5p
chr1
33332449
33332471
-
hsa-miR-15a-5p
chr13
50049167
50049188
-
hsa-miR-5688
chr3
85385761
85385782
+
hsa-miR-497-5p
chr17
7017979
7017999
-
hsa-miR-6838-5p
chr7
44073407
44073428
-
hsa-miR-4508
chr15
23562107
23562123
-
hsa-miR-34b-5p
chr11
111512950
111512972
+
hsa-miR-2682-5p
chr1
98045307
98045329
-
hsa-miR-499b-5p
chr20
34990443
34990463
-
hsa-miR-34c-5p
chr11
111513451
111513473
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL022157.1
chrX
57121662
57127243
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:945
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.